Bellevue Group Ag Vertex Pharmaceuticals Inc Transaction History

Bellevue Group Ag

$5.98 Billion
Q2 2024

A detailed history of Bellevue Group Ag transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bellevue Group Ag holds 593,461 shares of VRTX stock, worth $298 Million. This represents 4.65% of its overall portfolio holdings.

Number of Shares

593,461

Previous 668,750 11.26%

Holding current value

$298 Million

Previous $280 Million 0.49%

% of portfolio

4.65%

Previous 4.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $29.6 Million - $36.6 Million	-75,289 Reduced 11.26%	593,461 $278 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $27.6 Million - $30.2 Million	-67,640 Reduced 9.19%	668,750 $280 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $91.4 Million - $109 Million	-266,345 Reduced 26.56%	736,390 $300 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $31.9 Million - $34.2 Million	-94,431 Reduced 8.61%	1,002,735 $349 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $15.3 Million - $17.1 Million	-48,529 Reduced 4.24%	1,097,166 $386 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $14.1 Million - $16 Million	49,667 Added 4.53%	1,145,695 $361 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $17.7 Million - $20 Million	-62,098 Reduced 5.36%	1,096,028 $317 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $4.93 Million - $5.5 Million	-18,010 Reduced 1.53%	1,158,126 $335 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $71.5 Million - $89 Million	-304,117 Reduced 20.54%	1,176,136 $331 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $69 Million - $81.3 Million	-311,508 Reduced 17.39%	1,480,253 $386 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $5.34 Million - $6.74 Million	30,145 Added 1.71%	1,791,761 $393 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $5.06 Million - $5.67 Million	27,922 Added 1.61%	1,761,616 $320 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $66.9 Million - $78.9 Million	356,990 Added 25.93%	1,733,694 $350 Million
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $28.5 Million - $33.2 Million	137,719 Added 11.12%	1,376,704 $296 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $57.6 Million - $76.9 Million	278,385 Added 28.98%	1,238,985 $293 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $5.62 Million - $6.67 Million	-22,000 Reduced 2.24%	960,600 $261 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $65.5 Million - $85.9 Million	-290,489 Reduced 22.82%	982,600 $285 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $23.2 Million - $28.8 Million	-116,200 Reduced 8.36%	1,273,089 $303 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $6.64 Million - $8.92 Million	-39,850 Reduced 2.79%	1,389,289 $304 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $1.44 Million - $1.62 Million	8,650 Added 0.61%	1,429,139 $242 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $215 Million - $248 Million	1,303,500 Added 1114.21%	1,420,489 $260 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $374,777 - $445,668	2,289 Added 2.0%	116,989 $21.5 Million
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $11.3 Million - $14.3 Million	74,206 Added 183.25%	114,700 $19 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $301,914 - $346,932	-1,800 Reduced 4.26%	40,494 $7.81 Million
Q2 2018 Aug 07, 2018	SELL	$145.72 - $169.96 $7.94 Million - $9.27 Million	-54,516 Reduced 56.31%	42,294 $7.19 Million
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $90,960 - $106,278	600 Added 0.62%	96,810 $15.8 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $5 Million - $5.66 Million	36,410 Added 60.89%	96,210 $14.4 Million
Q3 2017 Nov 13, 2017	SELL	$148.13 - $162.24 $1.27 Million - $1.4 Million	-8,600 Reduced 12.57%	59,800 $9.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	68,400	68,400 $8.82 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Vertex Pharmaceuticals Inc Transaction History